Precision Medicine (Cluster two)
This cluster consolidates theme-based programmes focused on developing genetic, protein, metabolomic, imaging or phenotypic biomarkers to enable patient stratification to improve outcomes.
Its early discovery programmes will utilise high throughput molecular profiling and advanced imaging to identify clinically relevant biomarkers.
There has been a critical error on this website.